HEALEY ALS Platform Trial Weekly Q&A: January 12, 2023
Sabrina Paganoni, MD, PhD presented this week’s updates on the HEALEY ALS Platform Trial and answered questions from the audience. We were joined by guest speakers Michael Hotchkin (Chief Development Officer at Clene Nanomedicine, Inc) and James Berry, MD, MPH (Regimen C co-Lead, Mass General Hospital) to discuss the latest news and updates regarding Regimen C. Visit the Mass General website to register for future webinars: https://www.massgeneral.org/neurology....